.

Tuesday, January 21, 2014

Novartis Review

Novartis Novartis AG Latest results: Country: Sector: Bloomberg Ticker: Q4 2010 Switzerland dose company NVS.OL Industry view: familiarity view: Company military rating: Risk Quality Valuation taint the complete reputation Buy the complete Report pathetic MED. HIGH - - - Indigo Equity look Limited info@indigo-equity-research.com www.indigo-equity-research.com 15 Feb 2011 Investment Profile Note that this is a perfectly version of a to a greater extent complete (6 page) base on Novartis. Executive Summary Novartis has the profile of a mettlesome quality, gum elastic and reliable company. This is a reflection of Novartis having grown revenues, EPS and dividends relatively consistently over the last ten years, with stable avail margins. adapt is low and cash flow is strong. As a value linage the high dividend yield is crucial to its valuation. Overall, Novartis has performed well compared to its peers and given up the negative pharma industry trends. Cr itically, it has mostly avoided major legal proceeding & PR disasters of that other pharma companies have had. It is operationally diversify with pharma, vaccines & diagnostics, generics, and consumer health divisions.
Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!
Buy the complete report for more enlarge package bell - Last 10 eld 70 60 50 USD 40 30 20 10 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 0 NOVARTIS S&P 500 (Rebased) crownwork Structure component Price Number of Shares (bn) Market capitalization pull in (Debt) / Cash nonage Interests & Prefs Enterprise Value (EV) discharge Debt / Market Cap. Financial Results y/e 31 fall Sales EBIT Net Income Share Capital Tot! al additions FCF Per Share Data EPS DPS Cash EPS BV strength analysis EBIT Margin Net Profit Margin Asset Turnover Net gearing** ($) ($) ($) ($) 2010 ($ Bn) 50.6 11.5 9.8 63.2 123.3 11.8 2010 4.28 2.20 5.18 27.64 2010 22.8 % 19.3 % 41.1 % 195.1 % Per Share ($) 55.9 Total ($ Bn) 2.3 127.9 -14.9 142.8 12% 2012e ($ Bn) 60.2 9.8 7.6 69.0 129.9 8.3 2012e 3.32 2.84 3.61 30.20 2012e 16.3 % 12.6 % 46.3 % 188.1 % 11.0 % 2012e...If you want to get a full essay, order it on our website: OrderCustomPaper.com

If you want to get a full essay, visit our page: write my paper

No comments:

Post a Comment